Discover the latest advancements and challenges in the treatment of endometrial cancer, from therapeutic breakthroughs to the importance of diverse clinical trial enrollment, presented by leading experts in gynecologic oncology.
December 4th 2023
Delve into the exciting developments in endometrial cancer treatment, including HER2 antibody drug conjugates, checkpoint inhibitors, and the promising impact of these therapies in the quest to reduce chemotherapy use.
Experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD, explore the significance of enrolling diverse patients in clinical trials and the pivotal role of community settings in advancing endometrial cancer research and treatment.